한글목차

세계 수면무호흡증 진단 시스템 시장 규모는 2025년부터 2032년까지 7.10%의 CAGR로 확대되며 큰 폭으로 성장할 것으로 예상됩니다. 2025년 44억 7,000만 달러 규모인 이 시장은 수면 장애에 대한 인식의 증가와 기술 발전으로 2032년 72억 2,000만 달러에 달할 것으로 예상됩니다.

수면무호흡증 진단 시스템은 수면 중 호흡장애를 특징으로 하는 수면무호흡증후군의 평가 및 진단을 위해 고안된 첨단 장비입니다. 이 시스템은 기류, 호흡 노력, 산소포화도 등 중요한 생리적 파라미터를 모니터링하여 정확한 진단과 효과적인 치료 계획을 수립할 수 있도록 돕습니다. 전 세계적으로 수면무호흡증 유병률이 증가함에 따라 수면무호흡증 시장은 강력한 성장세를 보이고 있습니다. 휴대용 및 재택 진단 솔루션을 포함한 기술 혁신은 진단에 대한 접근성을 개선하고, 진단을 보다 환자 친화적이고 편리하게 만들었습니다.

수면무호흡증에 따른 건강 위험에 대한 인식이 높아짐에 따라 진단 솔루션에 대한 수요가 증가하고 있습니다. 헬스케어에 대한 적극적인 노력과 검진 프로그램은 조기 발견을 촉진하고 시장 성장에 기여하는 중요한 역할을 하고 있습니다.

재택 기반의 사용하기 쉬운 모니터링 솔루션의 출현은 수면무호흡증 진단에 혁명을 일으켰습니다. 이러한 시스템은 환자 중심의 의료 서비스로의 전환에 발맞춰 접근성을 높이고 채택률을 높이는 데 기여하고 있습니다.

세계의 수면무호흡증 진단 시스템 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 최종 용도별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 가격 분석, 2019-2023년

제4장 세계의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

• 세계의 수면무호흡증 진단 시스템 시장 전망, 제품 유형별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 수면무호흡증 진단 시스템 시장 전망, 최종 용도별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 수면무호흡증 진단 시스템 시장 전망, 지역별, 금액(10억 달러), 수량(100만 대), 2019-2032년

제5장 북미의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

제6장 유럽의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

제7장 아시아태평양의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

제8장 라틴아메리카의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 수면무호흡증 진단 시스템 시장 전망, 2019-2032년

제10장 경쟁 구도

• 형태별과 판매 채널별 히트맵
• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Braedon Medical Corporation
  • Advanced Brain Monitoring Inc.
  • SOMNOmedics GmbH
  • ResMed Inc.
  • BMC Medical Co. Ltd.
  • Natus Medical Incorporated
  • MGC Diagnostics Corporation
  • Cleveland Medical Devices Inc.

제11장 부록

영문목차

The global Sleep Apnea Diagnostic Systems Market is anticipated to witness substantial growth, registering a CAGR of 7.10% from 2025 to 2032. Starting at US$4.47 billion in 2025, the market is expected to reach US$7.22 billion by 2032, driven by increasing awareness of sleep disorders and technological advancements.

Sleep apnea diagnostic systems are advanced devices designed to assess and diagnose sleep apnea, a prevalent condition characterized by disrupted breathing during sleep. These systems monitor vital physiological parameters such as airflow, respiratory effort, and oxygen saturation, enabling accurate diagnosis and effective treatment planning. With a rising prevalence of sleep apnea cases globally, the market is experiencing robust growth. Technological innovations, including portable and home-based diagnostic solutions, have improved accessibility, making diagnosis more patient-friendly and convenient.

Market Growth Drivers

1.Growing Awareness and Screening Programs

Increased awareness of the health risks associated with untreated sleep apnea is driving demand for diagnostic solutions. Proactive healthcare initiatives and screening programs play a significant role in promoting early detection and contributing to market growth.

2.Technological Advancements

The emergence of home-based, user-friendly monitoring solutions has revolutionized sleep apnea diagnostics. These systems align with the shift toward patient-centric healthcare, offering greater accessibility and driving adoption rates.

3.Non-Invasive Diagnostics

Rising demand for non-invasive diagnostic solutions, combined with ongoing research to improve diagnostic accuracy, continues to propel the market forward.

Market Restraints

1.Regulatory Challenges

The stringent regulatory environment, encompassing complex approval processes and compliance standards, can delay product launches and affect market dynamics. New entrants often face difficulties in achieving regulatory compliance, which provides established players with a competitive advantage.

2.Adoption and Integration Hurdles

Resistance to transitioning from traditional in-lab polysomnography to modern technologies remains a challenge. Additionally, ensuring seamless integration of these diagnostic systems with existing healthcare IT infrastructure presents a barrier to widespread adoption.

Business Opportunities

1.Telemedicine Integration

The incorporation of telemedicine into sleep apnea diagnostic systems facilitates remote monitoring and consultations. This innovation expands market reach, particularly in underserved regions, and enhances patient engagement.

2.Wearable Technologies

Advances in wearable diagnostic devices provide non-intrusive, continuous monitoring options. These user-friendly solutions cater to individuals seeking proactive sleep health management, unlocking new market segments.

Regional Analysis

1.Europe: A Leading Market

Europe is a dominant market, supported by a strong healthcare infrastructure and a proactive stance toward managing sleep disorders. Countries like Germany, France, and the UK are leading in the adoption of advanced diagnostic technologies for sleep health.

2.South Asia & Pacific: Fastest-Growing Region

This region is experiencing remarkable growth due to increased healthcare awareness and a rising prevalence of lifestyle-related sleep disorders. Government initiatives and a growing middle-class population further drive demand for diagnostic systems.

3.North America

The region's emphasis on advanced healthcare technologies and heightened awareness of sleep apnea ensure consistent market growth.

Competitive Analysis

The Sleep Apnea Diagnostic Systems Market is highly competitive, with key players focusing on innovation, product differentiation, and strategic partnerships to enhance their market positions.

Key Companies:

• Koninklijke Philips N.V.
• Becton, Dickinson and Company
• Braedon Medical Corporation
• Advanced Brain Monitoring Inc.
• SOMNOmedics GmbH
• ResMed Inc.
• BMC Medical Co. Ltd.
• Natus Medical Incorporated
• MGC Diagnostics Corporation
• Cleveland Medical Devices Inc.

These organizations focus on innovation, ensuring regulatory compliance, and pursuing strategic collaborations to gain competitive advantages.

Sleep Apnea Diagnostic Systems Market Segmentation

1.By Product Type

• Polysomnography (PSG) Devices
• Ambulatory PSG Monitoring Devices
• Clinical PSG Monitoring Devices
• Sleep Apnea Screening Devices
• Nasal Flow Sensors
• Peripheral Capillary Oxygen Saturation (SPO2)
• Actigraphy Monitoring Devices

2.By End-Use

• Home Care Settings
• Hospitals
• Sleep Centers & Clinics

3.By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Sleep Apnea Diagnostic Systems Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2019 - 2023
• 3.2. Prominent Factor Affecting Sleep Apnea Diagnostic Systems Prices
• 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 4.1. Global Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Polysomnography (PSG) Devices
    • 4.1.1.2. Ambulatory PSG Monitoring Devices
    • 4.1.1.3. Clinical PSG Monitoring Devices
    • 4.1.1.4. Sleep Apnea Screening Device
    • 4.1.1.5. Nasal Flow Sensors
    • 4.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 4.1.1.7. Actigraphy Monitoring Devices
• 4.2. Global Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Home Care Settings
    • 4.2.1.2. Hospitals
    • 4.2.1.3. Sleep Centers & Clinics
• 4.3. Global Sleep Apnea Diagnostic Systems Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. North America
    • 4.3.1.2. Europe
    • 4.3.1.3. Asia Pacific
    • 4.3.1.4. Latin America
    • 4.3.1.5. Middle East & Africa

5. North America Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 5.1. North America Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Polysomnography (PSG) Devices
    • 5.1.1.2. Ambulatory PSG Monitoring Devices
    • 5.1.1.3. Clinical PSG Monitoring Devices
    • 5.1.1.4. Sleep Apnea Screening Device
    • 5.1.1.5. Nasal Flow Sensors
    • 5.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 5.1.1.7. Actigraphy Monitoring Devices
• 5.2. North America Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Home Care Settings
    • 5.2.1.2. Hospitals
    • 5.2.1.3. Sleep Centers & Clinics
• 5.3. North America Sleep Apnea Diagnostic Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. U.S. Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.2. U.S. Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.3. Canada Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.4. Canada Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 6.1. Europe Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Polysomnography (PSG) Devices
    • 6.1.1.2. Ambulatory PSG Monitoring Devices
    • 6.1.1.3. Clinical PSG Monitoring Devices
    • 6.1.1.4. Sleep Apnea Screening Device
    • 6.1.1.5. Nasal Flow Sensors
    • 6.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 6.1.1.7. Actigraphy Monitoring Devices
• 6.2. Europe Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Home Care Settings
    • 6.2.1.2. Hospitals
    • 6.2.1.3. Sleep Centers & Clinics
• 6.3. Europe Sleep Apnea Diagnostic Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Germany Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.2. Germany Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.3. U.K. Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.4. U.K. Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.5. France Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.6. France Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.7. Italy Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.8. Italy Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.9. Turkey Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.10. Turkey Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.11. Russia Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.12. Russia Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.13. Rest of Europe Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.14. Rest of Europe Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Polysomnography (PSG) Devices
    • 7.1.1.2. Ambulatory PSG Monitoring Devices
    • 7.1.1.3. Clinical PSG Monitoring Devices
    • 7.1.1.4. Sleep Apnea Screening Device
    • 7.1.1.5. Nasal Flow Sensors
    • 7.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 7.1.1.7. Actigraphy Monitoring Devices
• 7.2. Asia Pacific Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Home Care Settings
    • 7.2.1.2. Hospitals
    • 7.2.1.3. Sleep Centers & Clinics
• 7.3. Asia Pacific Sleep Apnea Diagnostic Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. China Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.2. China Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.3. Japan Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.4. Japan Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.5. South Korea Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.6. South Korea Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.7. South Korea Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.8. India Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.9. India Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.10. Southeast Asia Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.11. Southeast Asia Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.12. Rest of Asia Pacific Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.13. Rest of Asia Pacific Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 8.1. Latin America Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Polysomnography (PSG) Devices
    • 8.1.1.2. Ambulatory PSG Monitoring Devices
    • 8.1.1.3. Clinical PSG Monitoring Devices
    • 8.1.1.4. Sleep Apnea Screening Device
    • 8.1.1.5. Nasal Flow Sensors
    • 8.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 8.1.1.7. Actigraphy Monitoring Devices
• 8.2. Latin America Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Home Care Settings
    • 8.2.1.2. Hospitals
    • 8.2.1.3. Sleep Centers & Clinics
• 8.3. Latin America Sleep Apnea Diagnostic Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Brazil Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.2. Brazil Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.3. Mexico Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.4. Mexico Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.5. Argentina Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.6. Argentina Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.7. Rest of Latin America Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.8. Rest of Latin America Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Polysomnography (PSG) Devices
    • 9.1.1.2. Ambulatory PSG Monitoring Devices
    • 9.1.1.3. Clinical PSG Monitoring Devices
    • 9.1.1.4. Sleep Apnea Screening Device
    • 9.1.1.5. Nasal Flow Sensors
    • 9.1.1.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 9.1.1.7. Actigraphy Monitoring Devices
• 9.2. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook, by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Home Care Settings
    • 9.2.1.2. Hospitals
    • 9.2.1.3. Sleep Centers & Clinics
• 9.3. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. GCC Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.2. GCC Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.3. South Africa Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.4. South Africa Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.5. Egypt Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.6. Egypt Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.7. Nigeria Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.8. Nigeria Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.9. Rest of Middle East & Africa Sleep Apnea Diagnostic Systems Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.10. Rest of Middle East & Africa Sleep Apnea Diagnostic Systems Market by End Use, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Form vs Sales Channel Heatmap
• 10.2. Company Market Share Analysis, 2024
• 10.3. Competitive Dashboard
• 10.4. Company Profiles
  • 10.4.1. Koninklijke Philips N.V.
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Product Portfolio
    • 10.4.1.3. Financial Overview
    • 10.4.1.4. Business Strategies and Development
  • 10.4.2. Becton, Dickinson and Company
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Product Portfolio
    • 10.4.2.3. Financial Overview
    • 10.4.2.4. Business Strategies and Development
  • 10.4.3. Braedon Medical Corporation
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Product Portfolio
    • 10.4.3.3. Financial Overview
    • 10.4.3.4. Business Strategies and Development
  • 10.4.4. Advanced Brain Monitoring Inc.
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Product Portfolio
    • 10.4.4.3. Financial Overview
    • 10.4.4.4. Business Strategies and Development
  • 10.4.5. SOMNOmedics GmbH
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Product Portfolio
    • 10.4.5.3. Financial Overview
    • 10.4.5.4. Business Strategies and Development
  • 10.4.6. ResMed Inc.
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Product Portfolio
    • 10.4.6.3. Financial Overview
    • 10.4.6.4. Business Strategies and Development
  • 10.4.7. BMC Medical Co. Ltd.
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Product Portfolio
    • 10.4.7.3. Financial Overview
    • 10.4.7.4. Business Strategies and Development
  • 10.4.8. Natus Medical Incorporated
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Product Portfolio
    • 10.4.8.3. Financial Overview
    • 10.4.8.4. Business Strategies and Development
  • 10.4.9. MGC Diagnostics Corporation
    • 10.4.9.1. Company Overview
    • 10.4.9.2. Product Portfolio
    • 10.4.9.3. Financial Overview
    • 10.4.9.4. Business Strategies and Development
  • 10.4.10. Cleveland Medical Devices Inc.
    • 10.4.10.1. Company Overview
    • 10.4.10.2. Product Portfolio
    • 10.4.10.3. Financial Overview
    • 10.4.10.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations